000			02264 a2200625 4500
005			20250513094528.0
264		0	_c19961010
008			199610s 0 0 eng d
022			_a0889-2229
024	7		_a10.1089/aid.1996.12.683 _2doi
040			_aNLM _beng _cNLM
100	1		_aKeefer, M C
245	0	0	_aSafety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. _h[electronic resource]
260			_bAIDS research and human retroviruses _cMay 1996
300			_a683-93 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAIDS Vaccines _xadministration & dosage
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAmino Acid Sequence
650	0	4	_aCells, Cultured
650	0	4	_aConsumer Product Safety
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHIV Antibodies _xblood
650	0	4	_aHIV Envelope Protein gp120 _ximmunology
650	0	4	_aHIV Infections _ximmunology
650	0	4	_aHIV-1 _ximmunology
650	0	4	_aHumans
650	0	4	_aLeukocytes, Mononuclear _xcytology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Sequence Data
650	0	4	_aPolysorbates _xadministration & dosage
650	0	4	_aSqualene _xadministration & dosage
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aVaccines, Synthetic _xadministration & dosage
700	1		_aGraham, B S
700	1		_aMcElrath, M J
700	1		_aMatthews, T J
700	1		_aStablein, D M
700	1		_aCorey, L
700	1		_aWright, P F
700	1		_aLawrence, D
700	1		_aFast, P E
700	1		_aWeinhold, K
700	1		_aHsieh, R H
700	1		_aChernoff, D
700	1		_aDekker, C
700	1		_aDolin, R
773	0		_tAIDS research and human retroviruses _gvol. 12 _gno. 8 _gp. 683-93
856	4	0	_uhttps://doi.org/10.1089/aid.1996.12.683 _zAvailable from publisher's website
999			_c8741610 _d8741610